Near-infra-red fluorescent chitosan oligosaccharide lactate for targeted cancer imaging and photothermal therapy
Source abstract
Abstract
Photothermal therapy (PTT) is a promising approach for effective cancer treatment because of its non-invasive procedure, low toxicity to normal tissues, and high tumour ablation efficiency. Developing a PTT agent with precise tumour imaging capabilities is an essential prerequisite for effective PTT. In this study, we developed a bifunctional near-infra-red (NIR) fluorescent conjugate consisting of chitosan oligosaccharide lactate (COL) and the ZW800-1 NIR fluorophore (COL-ZW). We demonstrate that this conjugate is easy to use and that it is an effective theranostic agent for fluorescence-guided photothermal treatment. The temperature of COL-ZW increased by 62.3 °C after NIR laser irradiation (1.1 W/cm2) for 5 min in HT-29 tumour-bearing mice. The HT-29 tumours targeted by COL-ZW showed a remarkable decrease in tumour volume until a week after photothermal treatment. These in vivo results demonstrate that the bifunctional COL-ZW generates strong fluorescence and light-triggered PTT in tumour sites, indicating successful fluorescence-guided PTT. Importantly, no tumour recurrence or treatment-induced toxicity was observed after a single dose of COL-ZW with laser irradiation. Therefore, a combinatorial treatment with COL-ZW and NIR laser irradiation could serve as a promising strategy for photothermal cancer therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Photoacoustic and Ultrasonic Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Otolaryngology-Head and Neck Surgery, Chonnam National University Medical School
Department of Biomedical Sciences, Chonnam National University Medical School
Institute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea
Funding
National Research Foundation of Korea · Korea Government
References (30)
Show source-provided references
1. 10.1007/s12274-014-0620-y10.1007/s12274-014-0620-y ↗
2. 10.1002/adfm.20180283010.1002/adfm.201802830 ↗
3. 10.3390/cancers1109128610.3390/cancers11091286 ↗
4. 10.1080/21691401.2019.159318710.1080/21691401.2019.1593187 ↗
5. 10.1080/21691401.2019.162255410.1080/21691401.2019.1622554 ↗
6. 10.1021/ar800150g10.1021/ar800150g ↗
7. 10.1002/wnan.144910.1002/wnan.1449 ↗
8. 10.1080/21691401.2017.138438410.1080/21691401.2017.1384384 ↗
9. 10.1002/adfm.20140448410.1002/adfm.201404484 ↗
10. 10.1039/C7BM01210A10.1039/C7BM01210A ↗
11. 10.1016/j.biomaterials.2011.11.08110.1016/j.biomaterials.2011.11.081 ↗
12. 10.1002/ppsc.20170007610.1002/ppsc.201700076 ↗
13. 10.1021/cr400532z10.1021/cr400532z ↗
14. 10.1002/adma.20150248610.1002/adma.201502486 ↗
15. 10.2217/nnm.10.2310.2217/nnm.10.23 ↗
16. 10.1007/s13346-013-0144-010.1007/s13346-013-0144-0 ↗
17. 10.1016/j.pharmthera.2016.10.01310.1016/j.pharmthera.2016.10.013 ↗
18. 10.1016/j.carbpol.2019.11514310.1016/j.carbpol.2019.115143 ↗
19. 10.1039/C8TB01995A10.1039/C8TB01995A ↗
20. 10.1016/j.jconrel.2016.12.01210.1016/j.jconrel.2016.12.012 ↗
21. 10.1039/C8TB02823K10.1039/C8TB02823K ↗
22. 10.1038/s41598-017-18966-810.1038/s41598-017-18966-8 ↗
23. 10.3390/polym1003023210.3390/polym10030232 ↗
24. 10.1016/j.carbpol.2019.01.01010.1016/j.carbpol.2019.01.010 ↗
25. 10.1002/anie.20110245910.1002/anie.201102459 ↗
26. 10.1002/cmmi.148410.1002/cmmi.1484 ↗
27. 10.1038/nbt.246810.1038/nbt.2468 ↗
28. 10.1002/ppsc.20190049010.1002/ppsc.201900490 ↗
29. 10.7150/thno.3359510.7150/thno.33595 ↗
30. 10.1016/j.jiec.2018.02.00410.1016/j.jiec.2018.02.004 ↗